GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Roche Holding AG (OTCPK:RHHVF) » Definitions » Price-to-Funds-From-Operations

Roche Holding AG (Roche Holding AG) Price-to-Funds-From-Operations : (As of Apr. 27, 2024)


View and export this data going back to . Start your Free Trial

What is Roche Holding AG Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Roche Holding AG (Roche Holding AG) Business Description

Address
Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.